FDA Approves Diabetes Drug Mounjaro for Weight Loss Under New Name: Zepbound

In a highly anticipated decision, the U.S. Food and Drug Administration (FDA) has approved a weekly injected version of the type 2 diabetes drug Mounjaro (tirzepatide) for chronic weight management.